Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow Quality Index
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Quality Index of 0.93x as of March 2026. Operating cash flow of $59.59 Million is below net income of $63.73 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CPRX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Catalyst Pharmaceuticals Inc Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Catalyst Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc (CPRX) cash conversion ratio.
Annual Cash Flow Quality Index for Catalyst Pharmaceuticals Inc (2019–2025)
Year-by-year earnings quality comparison for Catalyst Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.97x | $208.67 Million | $214.33 Million | ▼ -33.5% |
| 2024 | 1.46x | $239.81 Million | $163.89 Million | ▼ -27.2% |
| 2023 | 2.01x | $143.60 Million | $71.41 Million | ▲ +44.0% |
| 2022 | 1.40x | $116.05 Million | $83.08 Million | ▼ -8.7% |
| 2021 | 1.53x | $60.37 Million | $39.48 Million | ▲ +154.6% |
| 2020 | 0.60x | $45.03 Million | $74.98 Million | ▼ -44.7% |
| 2019 | 1.09x | $34.61 Million | $31.88 Million | — |